Methods to capture proteomic and metabolomic signatures from cerebrospinal fluid and serum of healthy individuals
Abstract Discovery of reliable signatures for the empirical diagnosis of neurological diseases—both infectious and non-infectious—remains unrealized. One of the primary challenges encountered in such studies is the lack of a comprehensive database representative of a signature background that exists...
Main Authors: | Laura M. Lilley, Steven Sanche, Shepard C. Moore, Michelle R. Salemi, Dung Vu, Srinivas Iyer, Nicolas W. Hengartner, Harshini Mukundan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-16598-1 |
Similar Items
-
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
by: Michele Costanzo, et al.
Published: (2022-02-01) -
Proteomic and Metabolomic Signatures of Diet Quality in Young Adults
by: Elizabeth Costello, et al.
Published: (2024-01-01) -
Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
by: Henrik Carlsson, et al.
Published: (2021-02-01) -
Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
by: Probert, F, et al.
Published: (2021) -
Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases
by: Ji-Woong Kwon, et al.
Published: (2022-01-01)